RETN and rheumatoid arthritis: In this sense, resistin has also emerged as an adipokine implicated in the pathogenesis of OA and RA given its immunomodulatory effects and the ability to enhance the activated phenotype of the effector cells involved in these rheumatic diseases [98,129].